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We identified legislation (1989–2005) relating to breast and cervical cancer in Georgia, North
Carolina, and South Carolina and examined its impact on screening rates for these cancers and on
Black-White disparities in screening rates. Legislation was identi-fied using the National Cancer
Institute’s (NCI) State Cancer Legislative Database (SCLD) Program. Screening rates were
identified using the Centers for Disease Control and Prevention’s Behavioral Risk Factor
Surveillance System. Georgia and North Carolina enacted more laws on breast and cervical cancer
than did South Carolina. The laws specifically intended to increase breast and cervical cancer
screening were mandates requiring that insurance policies cover such screening; Georgia and
North Carolina enacted such laws, but South Carolina did not. However, we were unable to
demonstrate an effect of these laws on either screening rates or disparities. This may reinforce the
importance of evidence-based health promotion programs to increase screening.
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Except for skin cancer, breast cancer is the most common malignancy in women. Early
detection, which relies heavily on mammography for screening, is credited with reducing
mortality from breast cancer since the early 1990s. Cervical cancer is less common but, like
breast cancer, can be controlled through widespread use of screening and the early detection
of precancerous lesions through the Pap test.1,2
Between 1998 and 2003, the incidence of invasive cervical cancer was 8.9 per 100,000.
Rates were greater in minority populations, and in those living in the southern U.S.
compared with other parts of the U.S.3 The Pap test has reduced the incidence of cervical
cancer; even so, more than 60% of new cervical cancer cases occur in medically
underserved populations.4 There are many explanations proposed for why African American
women are less likely than White women to have a Pap smear, including lack of knowledge
about cervical cancer,5 having had a negative experience in the past when having a Pap
smear and pelvic exam,6 and being concerned about pain during the procedure.7 A family
history of cancer was found to contribute to the likelihood of one having a Pap smear8 and,
interestingly, a woman’s perception of general discrimination correlated with a reduced
likelihood of having the Pap test.9 Cervical cancer mortality has declined in the U.S. because
of the Pap smear,10 but Black women are two to three times more likely than White women
to die from the disease.
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Although breast cancer mortality has declined, African American women continue to
experience higher breast cancer mortality than White women.11 Furthermore, even though
African American women have a lower breast cancer incidence,12,13 they are more likely to
present with advanced stage distributions14–16 and are more likely to die of the disease,
compared with White women.17,18 Differences in breast cancer mortality are believed to be
due to lack of access to care,19 differences in screening rates, differences in treatment
received,20,21 inadequate follow-up after abnormal screening mammography or treatment,22
and differences in income or insurance coverage.23 Each of these differences is focused on
an individual’s circumstances, suggesting that should those circumstances change, mortality
rates between African American women and White women will be more similar.
The Southeastern U.S. Collaborative Center of Excellence in the Elimination of Disparities
(SUCCEED) focuses on the elimination of disparities in breast and cervical cancer among
African American women in the three-state region of Georgia, North Carolina, and South
Carolina. SUCCEED is housed in the Prevention Research Center (PRC) at Morehouse
School of Medicine (MSM) in Atlanta, Georgia. Overseen by the PRC’s consumer-majority
Community Coalition Board (CCB), SUCCEED collaborates with partners in the three-state
region, and provides training and technical assistance to agencies and organizations
throughout the region on evidence-based strategies to increase breast and cervical cancer
screening among African Americans. It also provides training and technical assistance in
community coalition-building using the Community Organization and Development for
Health Promotion model, a framework for the development of community partnerships that
was pioneered and published over 20 years ago at MSM.24
The focus of SUCCEED, and other similar efforts, is largely on evidence-based
interventions intended to influence individual behavior by motivating, persuading, or
educating women to seek screening. However, policy change at the population level can be
more effective than attempting to change individual behavior. For example, policy changes
affecting screening rates may include changes in eligibility for public programs, changes in
the number or distribution of sites where screening is available, changes in reimbursement
for providers, or changes in insurance regulations. Policy changes at the state level are
usually brought about by legislation. The purpose of this paper is to explore the effect of
recent legislation on breast and cervical cancer screening rates in Georgia, North Carolina,
and South Carolina. While increased screening clearly provides a means by which to reduce
mortality from breast and cervical cancer, state-level legislative support must be provided in
order to assure that women most at risk are able to access preventive services. Efforts to
increase screening are underway in these states; even so, it is important to explore whether
or not state legislation suf-ficiently supports these efforts.
Methods
We identified legislation focused on breast and cervical cancer in Georgia, North Carolina,
and South Carolina using the National Cancer Institute’s (NCI) State Cancer Legislative
Database (SCLD) Program. The SCLD contains information which has been synthesized
from state laws and resolutions addressing selected facets of cancer control, health
disparities, genetics, and tobacco. The NCI has monitored such legislation since 1989.
Online use access via the SCLD database was provided in 2005.
Queries of the database focused on the following search terms and limiters: (1) breast cancer
and (2) cervical cancer (a) awareness; (b) screening programs; (c) program evaluation; (d)
public education; (e) underserved populations; (f) treatment; and (g) research. This study
focused on the years 1989–2007.
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Screening rates were identified using the Centers for Disease Control and Prevention’s
Behavioral Risk Factor Surveillance System. Prevalence and trend data for Georgia, North
Carolina, and South Carolina focused on women aged 40 and over who had a mammogram
within the past two years and on women from the same states aged 18 and over who had Pap
tests within the past three years.
Results
Breast cancer legislation
In Georgia, six House of Representatives bills concerning breast cancer were enacted into
law between 1990–2002. The bills provided (1) requirements for individual and group
insurers to cover mammograms and Pap smears [two bills]; (2) provisions for in-patient and
follow-up care benefits for mastectomies; (3) monitoring of length of stay and discharges
from inpatient treatment for patients who have undergone mastectomies; (4) a cancer
research fund that allows for taxpayer contributions through individual income tax returns;
and (5) revenue funds for cancer screening and treatment via the sale of special license
plates. There was no relevant legislation in 1989, nor in 2003–2007.
In North Carolina, three State Senate and two House of Representatives bills concerning
breast cancer were enacted from 1991–1997, but none in 1989–90. The bills provided (1)
requirements for individual and group insurers to cover mammograms and Pap smears; (2)
requirements for Medicare supplement policies to cover mam-mograms and Pap smears; (3)
requirements for specified private insurers including HMOs, PPOs, and the Teachers’ and
State Employees’ Comprehensive Major Medical Plan to cover mastectomy and
reconstructive surgery; (4) requirements for specified health insurers that cover mastectomy
and post-mastectomy in-patient care to ensure discharge occurs after consultation with
patient and based on individual and medical history; (5) requirements for private insurers
that provide coverage for mastectomy to provide coverage for prosthesis and physical
complications in all stages of mastectomy, including lymphedemas.
In South Carolina, only one piece of breast cancer legislation was passed during the study
period, a House of Representatives bill that was enacted in 1998. The bill requires coverage
for hospitalization for mastectomies, benefits for hospitalization for at least 48 hours, and,
for patients with early release, coverage for at least one home care visit when ordered by
physician.
Hence, legislative efforts in Georgia and North Carolina were similar, while South
Carolina’s legislation was more limited and dissimilar (Table 1).
Cervical cancer legislation
In Georgia, one House of Representatives bill and one Senate bill were passed. The bills (1)
require individual and group insurers to cover mammograms and Pap smears, and (2)
establish the Cervical Cancer Elimination Task Force, respectively.
In North Carolina, one House of Representatives bill and three Senate bills were passed
between 2003 and 2009. The bills (1) require insurers to cover one annual exam and lab test
to screen for early detection of cervical cancer; (2) establish the Cervical Cancer Elimination
Task Force; (3) require local school administration to provide reproductive health and safety
programs (to include the effects of contracting HPV); and (4) require local boards of
education, charter schools, and public and private schools to provide information about
cervical cancer to children in the 5th–12th grades.
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In South Carolina, one House of Representatives bill was passed, which required the State
Department of Health and Environmental Control to study strategies and new technologies
that are effective in preventing and controlling cervical cancer.
Table 2 provides a visual comparison of legislation focused on cervical cancer in the three-
state region. Again, South Carolina is most limited in legislation passed.
Breast cancer screening rates
An analysis of the Centers for Disease Control and Prevention’s Behavioral Risk Factor
Surveillance System (CDC’s BRFSS) reveals that in Georgia in 2008, 78.9% (2,248/2,797)
of women aged 40 and over indicated that they had a mammogram within the past two
years. In North Carolina during the same time period, 78.5% (6,066/7,645) indicated that
they had received a mammogram. In South Carolina, 74.9% (3,982/5,146) of women had
received a mammogram within the past two years (Figure 1).
There were small differences in mammography rates by race in each state. In Geor-gia,
Black and White women indicated that they had a mammogram within the past two years
83.2% (n=511) and 78.1% (n=1,630) of the time, respectively. Black women in North
Carolina indicated that they had a mammogram within the past two years 78.2% (n=970) of
the time compared with 79.5% (n=4,773) of the time for White women. Similarly, in South
Carolina, Black women indicated that they had a mam-mogram within the past two years
77.3% (n=1,100) of the time compared with 75.1% (n = 2,606) of White women (Figure 2).
Cervical cancer screening rates
An analysis of the CDC’s BRFSS reveals that in Georgia in 2008, 87.6% (n=1,960) of
women aged 18 and over had a Pap test within the past three years. During the same time
period, 86.9% (n=5,432) and 86.1% (n=3,251) of women aged 18 and over had a Pap test
within the past three years in North Carolina and South Carolina, respectively (Figure 3).
Black and White women aged 18 and over in Georgia reported having had a Pap test within
the past three years 89.7% (n=544) and 86.6% (n=1277) of the time, respectively. In North
Carolina, 89.4% (n=890) of Black women and 86.6% (n=4,008) of White women aged 18
and over had a Pap test within the past three years. In South Carolina, 90.4% (n=1,009) of
Black women and 84.5% (n=2,028) of White women aged 18 years and over had a Pap test
within the past three years (Figure 4).
Discussion
We investigated the question of whether state legislation intended to promote breast and
cervical cancer screening was successful, either in increasing screening rates generally or in
reducing Black-White racial disparities in screening. We reviewed 1989–2005 legislation
and 2008 screening rates in Georgia, North Carolina, and South Carolina, the three states
included in SUCCEED, a project based at Morehouse School of Medicine and funded by
CDC’s REACH (Racial and Ethnic Approaches to Community Health) U.S. program.
Regarding breast cancer, Georgia was the most active of the three states, enacting five major
pieces of legislation, compared with two in North Carolina and one in South Carolina. North
Carolina enacted the most legislation in the area of cervical cancer with five new laws,
compared to two in Georgia and one in South Carolina. South Carolina was particularly
weak in this area: its lone bill required only that the state health department study new
strategies and technology. The Georgia and North Carolina laws that might have been
expected to have the greatest short-term impact were those mandating coverage in all health
insurance policies for Pap tests and mam-mograms. South Carolina did not enact these
mandates.
Miles-Richardson et al. Page 4













Of the three states, South Carolina did have the lowest rates of both mammogram and Pap
test uptake as reported by BRFSS, but the differences were small. About 79% of women in
Georgia and North Carolina reported that they had had a mammogram within the past two
years, compared with about 75% of South Carolina women. Similarly, about 88%, 87%, and
86% of women in Georgia, North Carolina, and South Carolina, respectively, reported
having had a Pap test within the past three years.
Racial differences were also small and inconsistent in direction. Black women were slightly
more likely than White women to report having had a mammogram in the past two years in
Georgia and South Carolina, while in North Carolina, the disparity slightly favored White
women. In all three states, Black women were somewhat more likely to report having had a
Pap test in the past three years than were White women.
In interpreting these findings, it is important to consider the limitations of the BRFSS
system. First, the BRFSS questions do not hold respondents to the frequency of screening
recommended by most professional organizations. Most women in the sample should have
obtained an annual Pap smear and mammogram to be up-to-date according to
recommendations. However, they were asked only if they had had a mam-mogram within
the past two years and a Pap test within the past three.
Second, BRFSS is dependent on self-reports, and these have been shown repeatedly to be
inaccurate for mammograms and Pap tests.25–28 A substantial percentage of women report
mammograms or Pap tests for which there is no medical record, or underestimate the
interval since their last mammogram or Pap. Moreover, African American women are more
likely to provide these inaccurate reports than are White women,29 and this has been shown
specifically to be true for the BRFSS.30,31
Given these limitations, it is probable that the percentage of women who are up-to-date in
screening for breast and cervical cancer in the three-state region is smaller than that
suggested by BRFSS.
However, there is no reason to believe that these self-reports are more inaccurate in one state
than in another; state-to-state comparisons are probably still valid. Thus, South Carolina,
which had the least legislation among the three states relating to breast and cervical cancer,
also had the lowest screening rates; these rates were only slightly lower than in the other two
states. Similarly, South Carolina had screening rates among African American women that
were similar to these rates in the other two states.
Thus, even though South Carolina enacted fewer new breast and cervical cancer-related laws
during 1989–2007, and did not enact insurance mandates, we were unable to demonstrate a
substantial difference in either overall screening rates or screening disparities in South
Carolina compared with Georgia and North Carolina. This is consistent with other studies of
legislation; for instance, Baker and Chan were unable to show an increase in screening rates
in states mandating insurance coverage for direct access to obstetrician-gynecologists.32
If legislation—in particular, an insurance mandate—is not effective in increasing screening
rates, then community-based strategies, such as those promoted by SUCCEED, are perhaps
more critical. Piedmont Health Services and Sickle Cell Agency is an example of an
organization in North Carolina that provides breast and cervical cancer education and
screenings to low-income, uninsured women. Efforts have led to breast and cervical cancer
screenings of 82% of women targeted. Additionally, the Samaritan Clinic in Albany,
Georgia has identified several ways to reach uninsured African American women using
efforts such as media campaigns and the use of cancer survivors in the community. They
have also collaborated with the Albany Baptist Ministers Conference to further enhance
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fundraising efforts and volunteerism. In a previously underserved area, the South Carolina
based St. James–Santee Family Health Center has increased screening rates (64–67%) to
approximate the national average mammography screening rates for community health
center patients (69%). The works of these and other organizations have the potential to
narrow the racial gap in screening. This is not to say that public policy initiatives or public
programs are unimportant. There is no doubt, for instance, that the National Breast and
Cervical Cancer Early Detection Program (NBCCEDP), Medicaid, and Medicare have
provided access to screening for women who would otherwise have little.33 Insurance
mandates, however, affect only women who have private insurance, and they are more likely
to be screened even if their policies do not provide first-dollar coverage.
In terms of increasing legislative support of breast and cervical cancer screening and
research, the role of advocacy organizations must be considered. For example, according to
the SCLD, the Georgia Breast Cancer Coalition Fund is credited for undertaking the effort
that led to the passage of House Bill 1402, enacted in 2002. This legislation establishes the
option of purchasing special license plates, with the revenue dedicated to increasing breast
cancer screening. No similar legislation was identified in North Carolina or South Carolina.
Interestingly, an Internet search for advocacy organizations in these three states reveals few
such organizations in South Carolina. This may help explain the limited legislation in that
state. However, since there is little evidence, either in our research or that of others, that new
legislation will substantially increase screening, it appears that the focus must be on
preserving support for current safety-net programs such as NBCCEDP, Medicaid, and
Medicare, and on increasing the use of evidence-based health promotion programs.
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Women aged 40 and over who had a mammogram within the past 2 years, by state.
Source: Centers for Disease Control and Prevention’s Behavioral Risk Factor Surveillance
System (2008).
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Women aged 40 and over who had a mammogram within the past 2 years, by state and race.
Source: Centers for Disease Control and Prevention’s Behavioral Risk Factor Surveillance
System (2008).
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Women aged 18+ who have had a pap test within the past 3 years.
Source: Centers for Disease Control and Prevention’s Behavioral Risk Factor Surveillance
System (2008).
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Women aged 18+who have had a pap test within the past 3 years, by state and race.
Source: Centers for Disease Control and Prevention’s Behavioral Risk Factor Surveillance
System (2008).
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Table 1
BREAST CANCER LEGISLATION IN GEORGIA (GA), NORTH CAROLINA (NC), AND SOUTH
CAROLINA (SC), 1989–2007
GA NC SC
Mandated mammogram coverage x x
Mandated mastectomy coverage x x x
Mandated coverage for mastectomy prostheses and complications x
Cancer Research Fund x
Cancer Screening and Treatment Fund x
Source: National Cancer Institute’s State Cancer Legislative Database.
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Table 2
CERVICAL CANCER LEGISLATION IN GEORGIA (GA), NORTH CAROLINA (NC), AND SOUTH
CAROLINA (SC), 1989–2007
GA NC SC
Mandated Pap test coverage x x
Cervical Cancer Elimination Task Force x x
Reproductive health education program required in schools x
Cervical cancer education program required in schools x
State Health Department required to study new strategies and technologies to prevent cervical cancer x
Source: National Cancer Institute’s State Cancer Legislative Database.
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